Paper Details
- Home
- Paper Details
A double-blind, placebo-controlled, dose-ranging safety evaluation of single-dose intravenous dolasetron in healthy male volunteers.
Author: BenedictC R, CramerM, HahneW F, HuntT L, ShahA, StewartW
Original Abstract of the Article :
The safety and tolerability of dolasetron mesylate, a potent and selective 5-HT3 receptor antagonist, were evaluated after single intravenous doses in healthy male volunteers. In this double-blind, placebo-controlled, randomized, phase I study, 80 subjects received either placebo or dolasetron in es...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1002/j.1552-4604.1995.tb04111.x
データ提供:米国国立医学図書館(NLM)
Dolasetron: A Potent Anti-Nausea Drug with a Safe Profile
Nausea and vomiting are common side effects of various medical treatments, including chemotherapy and surgery. This study investigates the safety and tolerability of dolasetron mesylate, a potent and selective 5-HT3 receptor antagonist, a type of drug that blocks serotonin receptors in the brain. The researchers conducted a double-blind, placebo-controlled study involving healthy male volunteers, administering escalating doses of dolasetron intravenously. They carefully monitored the participants for any adverse events, vital sign changes, and alterations in laboratory values.
Dolasetron: Well-Tolerated and Effective
The study's findings show that dolasetron was well-tolerated in healthy male volunteers, with most adverse events being mild in severity. The most commonly reported side effects included headache, dizziness, nausea, and increased appetite. It's like finding a cool oasis in a scorching desert—dolasetron provides relief from nausea and vomiting without causing significant adverse effects. These promising results suggest that dolasetron could be a safe and effective treatment for nausea and vomiting.
The Importance of Further Clinical Studies
While the study provides encouraging results, it is important to note that further clinical studies are needed to fully assess the effectiveness of dolasetron in various clinical settings. It's like navigating a vast desert with a new map—we need more data to understand the full potential of this promising drug.
Dr.Camel's Conclusion
This study is a beacon of hope for those who struggle with nausea and vomiting, offering a potential solution with a safe and tolerable profile. The researchers' careful evaluation provides valuable insights into the potential benefits of dolasetron. As further research unfolds, we can hope for a future where effective and safe antiemetic therapies are readily available to those who need them.
Date :
- Date Completed 1995-11-09
- Date Revised 2019-08-25
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.